ArticleInternational journal of molecular sciences2026
Computational Method Using Attribute-Aware Message Passing and Graph Convolutional Network for Potential miRNA-Disease Association Prediction.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
MicroRNA (miRNA) dysregulation is a crucial pathogenic factor that extensively participates in the occurrence and progression of various human diseases, especially cancers. Identifying unknown miRNA-disease connections is essential for understanding disease pathogenesis and improving clinical treatment strategies. Traditional biological experiments are often expensive and technically restricted, so computational prediction has become a widely used auxiliary research tool. In this study, we develop a novel predictive model called Attribute-Aware Message Passing Graph Convolutional Network (AAMPGCN) to identify potential miRNA-disease associations. The advantage of AAMPGCN lies in integrating miRNA and disease attribute information into the message-passing process: it partitions the miRNA-disease heterogeneous graph that incorporates miRNA functional similarity, disease semantic similarity, and Gaussian interaction kernel similarity into attribute-homogeneous subgraphs, while restricting high-order message propagation within each subgraph. This mechanism effectively filters cross-attribute noise, preserves the discriminability of miRNA and disease embeddings during deep convolution, and is thus well-adapted to miRNA-disease heterogeneous networks. The AAMPGCN prioritizes miRNA and disease attributes, aggregating messages specifically among nodes with similar attribute characteristics that are relevant to miRNA-disease interactions. Experimental results show that the AAMPGCN model achieves AUC and AUPR values of 94.06 and 93.52 on the HMDD2.0 dataset, which outperforms existing methods. The proposed AAMPGCN provides a new and effective method for miRNA-disease association prediction, and also offers theoretical support for the research on disease molecular mechanisms and the screening of clinical therapeutic targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.